| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020251 |
| Receipt No. | R000023381 |
| Official scientific title of the study | Internal organs fat decrease effect confirmation examination in long-term aging vinegar "KOZU" (Double-blind study) |
| Date of disclosure of the study information | 2016/01/10 |
| Last modified on | 2016/11/01 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Internal organs fat decrease effect confirmation examination in long-term aging vinegar "KOZU" (Double-blind study) | |
| Title of the study (Brief title) | Internal organs fat decrease effect confirmation examination in vinegar "KOZU" (NKJ-1 study) | |
| Region |
|
|
| Condition | ||
| Condition | BMI value is higher Japanese | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To target a monitor that is definition and BMI increased , to confirm the effect of reducing visceral fat when it is allowed to continue ingestion of the test substance |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visceral fat area of the abdomen (Intervention before 4 weeks , before the start , after 12 weeks) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects(long-term aged vineger"KOZU") eat 15mL/day for 12 weeks | |
| Interventions/Control_2 | The subjects(short-term aged vineger"KOZU") eat 15mL/day for 12 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)The healthy person who does not have a serious disease
2)And wish to voluntarily participate in a clinical trial following 60 years of age or 30 years of age , who written consent is obtained 3)Who can ingest the vinegar 4)BMI (Body Mass Index) of 23 or more , of less than 30 persons 5)Who can maintain the daily life weekly during the test period at a constant |
|||
| Key exclusion criteria | 1)Diabetes, heart disease, kidney disease, liver disease, those who have a medication for the treatment of hypertension such as
2)Severe disease (cancer, heart disease, kidney disease, etc.) A person with a history of 3)A person more than three times the reference value upper limit of liver function and renal function test values 4)Persons with food allergies and drug allergy related to the food test 5)Those who have had surgery of the digestive tract 6)Those who have regular specified health food and functional food display related to the cholesterol blood sugar suppress and bowel movement improvement (indigestible dextrin, plant sterols, chitosan, those including psyllium seed coat) a 7)Those persons and in the diet to the violent sport 8)Those who are participating in other clinical trials within the past one month 9)Hot flashes, dizziness, there are subjective symptoms of menopause symptoms of sweating like a person 10)Persons under postmenopausal three years 11)Who you are wearing a pacemaker 12)Those who participate in the study investigator were disqualified |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Hiromu Katsuta |
| Organization | Relife-inc |
| Division name | Clinical Development Division |
| Address | Koshin BLD 501 1-47-1 Higashi-Ikebukuro Toshima-ku Tokyo |
| TEL | 03-5928-2501 |
| hkatsuta@relife-inc.com | |
| Public contact | |
| Name of contact person | Hiromu Katsuta |
| Organization | Relife-inc |
| Division name | Clinical Development Division |
| Address | Koshin BLD 501 1-47-1 Higashi-Ikebukuro Toshima-ku Tokyo |
| TEL | 03-5928-2501 |
| Homepage URL | |
| hkatsuta@relife-inc.com | |
| Sponsor | |
| Institute | Kojun Japan co.,ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kojun Japan co.,ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023381 |